Verastem (VSTM) Return on Capital Employed (2012 - 2026)

Verastem (VSTM) recorded quarterly Return on Capital Employed of 26.26% in Q1 2026, up 16.8% quarter-over-quarter from 31.56% in Q4 2025, and up 13556.0% on a YoY basis from N/an in Q1 2025.

Verastem (VSTM) Return on Capital Employed (2012 - 2026) Analysis & Trends

Verastem's Return on Capital Employed history runs 15 years deep, the most recent figure standing at 26.26% for Q1 2026.

  • In Q1 2026, Return on Capital Employed rose 13556.0% year-over-year to 26.26%; the TTM figure through Mar 2026 stood at 26.26% (up 13556.0% YoY), while the FY2025 annual figure was 43.24%, up 7820.0% from the prior year.
  • Return on Capital Employed was 26.26% for Q1 2026 at Verastem, up from 31.56% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 26.26% in Q1 2026 to a low of 161.82% in Q1 2025.
  • Historically, Return on Capital Employed has averaged 91.64% across 5 years, with a median of 87.96% in 2023.
  • The sharpest annual moves came in 2024 and 2026: Return on Capital Employed tumbled 9694 bps in 2024, then soared 13556 bps in 2026.
  • A 5-year view of Return on Capital Employed shows it stood at 89.59% in 2022, then increased by 25 bps to 67.43% in 2023, then tumbled by 105 bps to 138.53% in 2024, then soared by 77 bps to 31.56% in 2025, then increased by 17 bps to 26.26% in 2026.
  • The last three Return on Capital Employed figures came in at 26.26% (Q1 2026), 31.56% (Q4 2025), and 126.33% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 450.31%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 51.73%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -107.40%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 21.10%
9 Abivax 91.96 Bn 91.96 Bn - -50.43%
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn -26.26%

Historic Data

Download Data
DateValue
Mar 31, 2026 -26.26%
Dec 31, 2025 -31.56%
Sep 30, 2025 -126.33%
Jun 30, 2025 -137.79%
Mar 31, 2025 -161.82%
Dec 31, 2024 -138.53%
Sep 30, 2024 -145.52%
Jun 30, 2024 -117.19%
Mar 31, 2024 -91.72%
Dec 31, 2023 -67.43%
Sep 30, 2023 -48.58%
Jun 30, 2023 -54.74%
Mar 31, 2023 -87.96%
Dec 31, 2022 -89.59%
Sep 30, 2022 -86.56%
Jun 30, 2022 -79.08%
Mar 31, 2022 -67.30%
Dec 31, 2021 -66.98%
Sep 30, 2021 -59.08%
Jun 30, 2021 -27.02%